Suppr超能文献

丙型肝炎病毒感染是肝切除术治疗早期肝细胞癌的不良预后因素:对符合肝移植条件的肝细胞癌管理的影响。

Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.

机构信息

Department of Digestive Surgery, Hôpital Saint Antoine, 184, rue du faubourg Saint Antoine, 75012 Paris, France.

出版信息

Ann Surg Oncol. 2013 Jul;20(7):2405-12. doi: 10.1245/s10434-012-2861-x. Epub 2013 Jan 23.

Abstract

INTRODUCTION

Recent data support liver resection (LR) as first-line approach in patients with preserved liver function who have resectable/transplantable hepatocellular carcinoma (HCC). This study was designed to evaluate the outcome of LR in patients with transplantable HCC.

METHODS

Between 1998 and 2009, 75 patients (65 men, mean age 61 ± 11 years) with HCC eligible for liver transplantation (LT) underwent LR. The underlying hepatic disease was related to hepatitis C (HCV) in 30 (40 %) patients, hepatitis B (HBV) in 15 (20 %) patients, alcohol abuse in 26 patients (36 %) and other in 10 patients (13 %). Fifty-five (73 %) patients had cirrhosis. Intermittent clamping of the hepatic pedicle was used in 41 (55 %) patients. Treatment of recurrence by salvage LT was performed in 6 (8 %) patients.

RESULTS

Operative morbidity and mortality rates were 37 and 5 % respectively. At 1, 3, and 5 years, overall (OS) and disease-free (DFS) survival rates were 81, 69,55 and 56, 31, and 21 %, respectively. On multivariate analysis, HCV infection was the only independent factor associated with decreased OS (p = 0.02). On multivariate analysis, HCV infection (p = 0.05) and intermittent hepatic pedicle clamping (p = 0.003) were associated with decreased DFS. The 1-, 3-, and 5-year OS and DFS rates in patients with HCV-related HCC were 69, 53, 38 and 50, 18, and 9% respectively.

CONCLUSIONS

Overall and disease-free survival after liver resection in patients with HCV-related HCC and preserved liver function is poor. Primary LT should be offered to these patients.

摘要

介绍

最近的数据支持在肝功能正常且可切除/可移植的肝细胞癌(HCC)患者中,采用肝切除术(LR)作为一线治疗方法。本研究旨在评估可移植 HCC 患者接受 LR 的结果。

方法

1998 年至 2009 年,75 例符合肝移植(LT)条件的 HCC 患者接受了 LR。其中 30 例(40%)患者的基础肝脏疾病与丙型肝炎(HCV)有关,15 例(20%)患者与乙型肝炎(HBV)有关,26 例(36%)患者与酒精滥用有关,10 例(13%)患者与其他原因有关。55 例(73%)患者有肝硬化。41 例(55%)患者采用间歇性肝蒂夹闭。6 例(8%)患者因复发而行挽救性 LT 治疗。

结果

手术发病率和死亡率分别为 37%和 5%。1、3 和 5 年的总生存率(OS)和无病生存率(DFS)分别为 81%、69%、55%和 31%、21%。多因素分析显示,HCV 感染是与 OS 降低相关的唯一独立因素(p=0.02)。多因素分析显示,HCV 感染(p=0.05)和间歇性肝蒂夹闭(p=0.003)与 DFS 降低相关。HCV 相关 HCC 患者的 1、3 和 5 年 OS 和 DFS 率分别为 69%、53%、38%和 50%、18%和 9%。

结论

HCV 相关 HCC 且肝功能正常的患者接受 LR 后总体生存率和无病生存率较差。应向这些患者提供原发性 LT。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验